Quality in the Boardroom™ Launches: Leading at the Edge of MedTech Innovation
MedTech Impact Partners is proud to announce the debut of a new series, Quality in the Boardroom™, in partnership with Quality Means Business. In the premiere episode, Rajit Kamal shared powerful insights on how forward-thinking MedTech organizations are leveraging technology and Design Risk Management (DRM) to stay ahead of the curve.
Featured Conversation: Kwame Joins A.J. Fortier for an Industry Dialogue
We’re thrilled to announce that a recent conversation between Kwame Ulmer and A.J. Fortier, Managing Partner at MedTech Impact Partners (MIP), has been featured on LinkedIn, YouTube, and major podcast platforms.
The Power of Integration: MedTech Impact Partners & Boulder Clinical Science
We're excited to share that MedTech Impact Partners and Boulder Clinical Science have formed a strategic partnership. This collaboration brings together best-in-class regulatory strategy and efficient clinical trial execution, offering a comprehensive solution for de-risking drug and device development.
Executive Roundtable Recap: Navigating the Evolving MedTech Landscape
Key Takeaways from our recent "Thriving in Uncertain Times" Executive Roundtable
Kwame Ulmer from MedTech Impact Partners to Deliver Keynote at MedTech Malta 2024
Each year, the world’s leading medtech and healthtech innovators, experts, and investors converge at MedTech Malta, setting new standards for the industry. MedTech Malta 2024 promises to be no exception, and among the distinguished keynote speakers is Kwame Ulmer, Managing Partner at MedTech Impact Partners, who will share his insights and expertise on the global stage. With a distinguished career spanning over two decades in digital health, cardiovascular care, and ophthalmology, Ulmer has played pivotal roles, including serving as Deputy Division Director at the FDA and Vice President of Regulatory Affairs/Quality Assurance at Fortune 150 company, Danaher. His extensive background in both the public and private sectors positions him as a leading voice in MedTech innovation.
Essenvia Releases 2024 State of US MedTech Regulation Report
Now that the MedTech industry has 2023 in its rear-view mirror, it’s ready to tackle fresh, oncoming challenges head-on. With its brand-new “2024 State of US MedTech Regulation” report, Essenvia has pinpointed eight specific hurdles that many medical device manufacturers will have to jump in the coming years.
MedTech Color Announces the 4th Annual Pitch Competition Top Winners
MedTech Color Announces the 4th Annual Pitch Competition Top Winners: MedTech Color’s 4th Annual MedTech Color Pitch Competition took place on March 15, 2024, at Covel Commons on the UCLA campus in Los Angeles, California. The highly anticipated event focused on identifying and supporting the next generation of founders aiming to diversify and bring innovation to the medical technology field, with a particular focus on African-American and Hispanic entrepreneurs.
Medical Device Data and Evidence: An Integrated Approach
One of the most formidable challenges in bringing a medical device to market is generating clinical and commercial evidence for a diverse group of stakeholders, such as the FDA, insurance payers and healthcare providers. It’s a complicated process where any misstep can lead to costly delays and a loss of profits.
Join Orthogonal for a webinar bringing together distinguished MedTech leaders to share insights, case studies and best practices for developing effective evidence gathering strategies.
Future-Proofing Your Global Company and More with Kwame Ulmer
What investment trends are currently dominating the American Healthcare industry? What are entrepreneurs to do in the wake of rapid regulatory advancements? These questions and more were discussed in Future proof your Global Company, an enlightening presentation given by Mr. Kwame Ulmer during MedTech Malta last October.
Panel Recap: Investment Perspective, Insights, & Increasing Representation | LSI Europe '23
This panel took place at LSI Europe ‘23 Emerging Medtech Summit in Barcelona, Spain and explores diverse investment perspectives and insights with regard to fostering increased representation and inclusivity within the Medtech ecosystem.
The moderator, Kwame Ulmer of MedTech Impact Partners, was joined by:
Tracy Dooley — Avestria Ventures
Nicole J. Walker — Venture Investor
Esther Reynal de St Michel Richardot — THENA Capital
Unlocking Insights with Kwame Ulmer: A Journey Through MedTech, FDA, and Venture Capital
This interview with Kwame Ulmer is part of a larger series of interviews where we discuss the intersection of healthcare and technology with subject matter experts from Adhera Health’s Advisory Board.
Kwame Ulmer leads MedTech Impact Partners (MIP), bringing over twenty years of experience evaluating medical technologies from both government and private sectors. In addition, Mr. Ulmer is a venture partner at Wavemaker Three-Sixty Health, the leading Southern-California based, early-stage venture capital firm focused on the healthcare industry.
MedTech Impact Partners Grows Regulatory Support Expertise
MedTech Impact Partners is pleased to announce that Marie Rigley has joined our regulatory support team as a Senior Regulatory Associate. Marie Rigley has more than a decade of experience as a regulatory professional supporting and advising medical device companies.
CellKey Partnership Poised to Reshape Bioanalytical Research
This dynamic collaboration propels us into an exciting journey to revolutionize protein and glycoprotein analysis, a critical domain for diagnosing and treating diseases, including cancer.
From Student to Board Member: Crafting a Lasting Lincoln Legacy
Kwame Ulmer, Lincoln University Class of ’96, is one of Lincoln University’s most prominent advocates. With an unwavering commitment to education and healthcare, this successful entrepreneur has channeled his resources and dedication into supporting Lincoln University, leaving a historical mark on our legacy.
MDisrupt + MedTech Impact Partners | A Partnership to Provide More Regulatory Support to Digital Health Companies
Medtech Impact Partners is partnering with MDisrupt to meet the growing need for regulatory support and strategy. Through this collaboration, MedTech Impact Partners and MDisrupt are providing streamlined access to industry leading regulatory experts on demand, providing crucial support for minimizing risks, avoiding delays, and ultimately bringing innovative healthcare solutions to patients efficiently and safely.
MIP Job Announcement | Regulatory Associate
MedTech Impact Partners is a medical device regulatory strategy consulting firm, leveraging deep executive-level experience from the USFDA, private sector and world-class research to deliver expert insights for companies, law firms and investors.
We are looking for an experienced Regulatory Associate to work as a remote consultant with MedTech Impact Partners.